Table 3.
High risk exposure | Patients | Controls | Adjusted odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | ||
---|---|---|---|---|---|---|---|---|
Genotype | Ever | Never | Ever | Never | Ever | Never | ||
Parity | ||||||||
A/A | 79 | 12 | 112 | 15 | Referent | Referent | ||
G/A | 228 | 29 | 241 | 35 | 1.347 (0.956–1.897) | 0.0881 | 1.129 (0.443–2.878) | 0.7954 |
G/G | 121 | 17 | 95 | 13 | 1.323 (1.083–1.615) | 0.0059 | 1.289 (0.752–2.209) | 0.3447 |
G/A + G/G | 349 | 46 | 336 | 48 | 1.484 (1.071–2.055) | 0.0174 | 1.274 (0.526–3.085) | 0.5876 |
Oral contraceptive use | ||||||||
A/A | 41 | 50 | 56 | 71 | Referent | Referent | ||
G/A | 116 | 141 | 119 | 157 | 1.558 (0.944–2.573) | 0.0818 | 1.314 (0.853–2.024) | 0.2145 |
G/G | 66 | 72 | 47 | 61 | 1.376 (1.043–1.816) | 0.0232 | 1.278 (0.991–1.648) | 0.0571 |
G/A + G/G | 182 | 213 | 166 | 218 | 1.589 (1.001–2.523) | 0.0509 | 1.407 (0.934–2.121) | 0.1018 |
Smoking | ||||||||
A/A | 28 | 63 | 43 | 84 | Referent | Referent | ||
G/A | 90 | 167 | 94 | 182 | 1.667 ().933–2.976) | 0.0829 | 1.220 (0.826–1.803) | 0.3169 |
G/G | 59 | 79 | 37 | 71 | 1.666 (1.195–2.322) | 0.0024 | 1.196 (0.948–1.508) | 0.1288 |
G/A + G/G | 149 | 246 | 131 | 253 | 1.958 (1.133–3.384) | 0.0157 | 1.306 (0.900–1.896) | 0.1586 |
Menopausal status | ||||||||
Premenopausal | Postmenopausal | Premenopausal | Postmenopausal | Premenopausal | Postmenopausal | |||
A/A | 27 | 64 | 47 | 80 | Referent | Referent | ||
G/A | 105 | 152 | 108 | 168 | 1.739 (1.000–3.023) | 0.0501 | 1.197 (0.800–1.791) | 0.3796 |
G/G | 39 | 99 | 42 | 66 | 1.381 (0.981–1.939) | 0.0606 | 1.334 (1.059–1.679) | 0.0138 |
G/A + G/G | 144 | 251 | 150 | 234 | 1.662 (0.977–2.826) | 0.0602 | 1.367 (0.938–1.992) | 0.1035 |
CI confidence interval
All p values were adjusted by age. Significant results are highlighted in bold font